metricas
covid
Annals of Hepatology Chronic Administration of DEN and 2-AAF for 13 and 18 weeks in Wistar Rats Leads...
Journal Information
Vol. 30. Issue S1.
Abstracts Asociación Mexicana de Hepatología (AMH) 2024
(April 2025)
Vol. 30. Issue S1.
Abstracts Asociación Mexicana de Hepatología (AMH) 2024
(April 2025)
Full text access
Chronic Administration of DEN and 2-AAF for 13 and 18 weeks in Wistar Rats Leads to Progress of Hepatocarcinogenesis
Visits
382
Jaime Sánchez-Meza1, Marina Campos-Valdez1, José A. Domíngez-Rosales1, Juliana M. Godínez-Rubí2, Sarai C. Rodríguez-Reyes3, Erika Matínez-López3, Adriana M. Salazar-Montes1, Carmen M. Gurrola Díaz1, Manuel A. Castro-García1, Guillermo M. Zúñiga-González4, Laura V. Sánchez Orozco1
1 Institute of Chronic Degenerative Diseases, University Center for Health Sciences, University of Guadalajara, Guadalajara, Jalisco, Mexico
2 Laboratory of Diagnostic Pathology and Immunohistochemistry, Department of Microbiology and Pathology, University Center for Health Sciences, University of Guadalajara, Guadalajara, Jalisco, Mexico
3 Institute of Translational Nutrigenetics and Nutrigenomics, University Center for Health Sciences, Guadalajara, Jalisco, Mexico
4 Laboratory of Mutagenesis, Western Biomedical Research Center, IMSS, Guadalajara, Jalisco, Mexico
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Special issue
This article is part of special issue:
Vol. 30. Issue S1

Abstracts Asociación Mexicana de Hepatología (AMH) 2024

More info
Introduction and Objectives

Induction of hepatocellular carcinoma by administration of the agents diethylnitrosamine (DEN) and N-(2-Fluorenyl) acetamide (2-AAF) in murine animals, is a model to study liver cancer. The objective was to evaluate the alterations triggered by the chronic administration of DEN and 2-AAF during 13 and 18 weeks (wks.) in Wistar rats.

Materials and Patients

Male Wistar rats (180-200 g) were organized in groups: a) Control 18 wks. (18-wk Ctl; n=6); b) Damage 18 wks. (18-wk Dmg; n=8), c) Control 13 weeks. (13-wk Ctl; n=5), and d) Damage 13 wks. (13-wk Dmg; n=6). The 13- and 18-wk Dmg groups were weekly treated with i.p DEN (50 mg/Kg) on day one and with i.g. 2-AAF (25 mg/Kg) on day three; the treatment (Tx) was maintained over 13 and 18 weeks, respectively. Then, livers and serum were collected for histological, serum biochemistry, and gene expression analyses. Statistical test Student's t-tests or Kruskal-Wallis and Mann-Whitney U were performed using the software GraphPad Prism version 8. A p value < 0.05 was considered significant.

Results

The rat's survival decreased to 62.5% with the Dmg Tx for the 18-wk Dmg group at the tenth week, but when the 13-wk Dmg group was included, the survival increased to 78.5% (n= 14) until the thirteenth week. Dmg Tx tended to decrease the animal's weight and induced changes in the liver tissue (paler coloration, differentiated nodules, and hepatomegaly; to a lesser degree in the 13-wk Dmg group). Heterogeneity in the damage severity was detected among the animals of both groups, which was also found at the histological level, where there were clear signals of loss of normal hepatocyte architecture, lobular structure disorder, atypical cell enhancement, and accumulation of collagen. Probable lung metastasis was recognized in the 18-wk Dmg group (indicated by macroscopic and histological alterations). In the Dmg groups, the levels of ALT, AST, ALKP, GGT, and total proteins in serum were significantly altered; as well as CAT, SOD, COL1A, and TGFB1 expression were significantly different. In addition, IL6 was also increased in the 18-wk Dmg group.

Conclusions

Dmg Tx during 13 wks. is sufficient to induce significant alterations and the 18-wk Tx exhibited possible lung metastasis. The heterogeneity in this model may be seen as a disadvantage; yet, this may be taken as a depiction of the heterogeneity found in liver cancer patients in real life.

Full Text

Ethical statement: The study protocol (code CI-01720) was approved by the Ethics, Research, and Biosecurity Committee of the CUCS, Universidad de Guadalajara on 20 October 2020.

Declaration of interests: None.

Funding: Grant PIN 2021 CUCS, UdeG, P3E 271879-2023 and PRO SNI, UdeG.

Download PDF
Article options
Tools